Randomized clinical stroke trials in 2003
Related Experiment Video
Updated: Aug 23, 2026
The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
Published on: December 19, 2025
1Burke Rehabilitation Hospital and Medical Research Institute, Weill Medical College of Cornell University, 785 Mamaroneck Avenue, White Plains, NY 10605, USA. mrabadi@burke.org
Insights
Treating hypertension, hyperlipidemia, and atrial fibrillation reduces future strokes. However, female hormone therapy showed no benefit, while donepezil may help stroke-related dementia.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Clinical Trials
Background:
- Stroke remains a leading cause of long-term disability.
- Identifying effective interventions for stroke prevention and management is crucial.
- Understanding the impact of treating modifiable risk factors is essential for public health.
Purpose of the Study:
- To review randomized clinical trials published in 2003 focusing on stroke risk factor modification.
- To evaluate the efficacy of various treatments in reducing future stroke incidence.
- To assess the impact of interventions on post-stroke cognitive impairment.
Main Methods:
- Analysis of randomized clinical trials published in 2003.
- Review of studies investigating treatments for hypertension, hyperlipidemia, and atrial fibrillation.
- Evaluation of trials on hormone replacement therapy and donepezil for stroke patients.
Main Results:
- Treatments for hypertension, hyperlipidemia, and atrial fibrillation (using a new anticoagulant) demonstrated significant benefits in reducing future strokes.
- Female hormone therapy was found to be not beneficial for stroke prevention.
- Donepezil showed potential as a treatment for post-stroke dementia.
Conclusions:
- Aggressive management of hypertension, hyperlipidemia, and atrial fibrillation is key to stroke risk reduction.
- Female hormone therapy is not recommended for preventing strokes.
- Donepezil represents a promising therapeutic option for cognitive deficits following stroke.
Abstract:
Randomized clinical stroke trials published during 2003 dealt with what impact treatment of stroke risk factors have on reducing future strokes. Treatment of hypertension and hyperlipidemia, and atrial fibrillation with a new anticoagulant, were confirmed to be beneficial. Treatment with female hormones was not beneficial. A potentially important study indicated that donepezil is a useful treatment for dementia in people who have had strokes.
